Literature DB >> 1036910

Irreversible protein binding of 14C-imipramine in rats in vivo.

H Kappus.   

Abstract

Forty-eight hours after a single dose of 14C-imipramine to rats, 14C-radioactivity could be measured in the following organs: liver greater than kidney greater than serum greater than fat greater than spleen greater than duodenum greater than lung greater than muscle and brain. Liver microsomes contained the main part of radioactivity derived from 14C-imipramine. After exhaustive extraction, only the proteins of liver, kidney, spleen, lung and serum contained measurable amounts of radioactive labeling. The greatest amount of 14C-imipramine irreversibly bound to proteins was detected in liver microsomes. The question, as to whether the irreversible protein binding of imipramine, if it occurs during therapy, results in toxic side-effects, is discussed.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1036910     DOI: 10.1007/BF00353357

Source DB:  PubMed          Journal:  Arch Toxicol        ISSN: 0340-5761            Impact factor:   5.153


  18 in total

1.  JAUNDICE DURING IMIPRAMINE TREATMENT.

Authors:  P C HOAKEN
Journal:  Can Med Assoc J       Date:  1964-06-13       Impact factor: 8.262

2.  Loeffler's syndrome occurring during imipramine therapy.

Authors:  I C WILSON; J M GAMBILL; M G SANDIFER
Journal:  Am J Psychiatry       Date:  1963-03       Impact factor: 18.112

3.  [Treatment of depressive states with an iminodibenzyl derivative (G 22355)].

Authors:  R KUHN
Journal:  Schweiz Med Wochenschr       Date:  1957-08-31

Review 4.  Poisoning by tricyclic antidepressant drugs: general and pharmacokinetic considerations.

Authors:  M H Bickel
Journal:  Int J Clin Pharmacol Biopharm       Date:  1975-03

5.  Lethal hepatic necrosis after therapy with imipramine and desipramine.

Authors:  W J Powell; J Koch-Weser; R A Williams
Journal:  JAMA       Date:  1968-10-14       Impact factor: 56.272

6.  Agranulocytosis after desipramine.

Authors:  J L Crammer; A Elkes
Journal:  Lancet       Date:  1967-01-14       Impact factor: 79.321

7.  Imipramine and chlorpromazine in hepatic microsomal systems.

Authors:  J M Perel; L O'Brien; N B Black; G D Bellward; P G Dayton
Journal:  Adv Biochem Psychopharmacol       Date:  1974

8.  Tissue localization of 7- and 8-hydroxychlorpromazines.

Authors:  R P Maickel; N M Fedynskyj; W Z Potter; A A Manian
Journal:  Toxicol Appl Pharmacol       Date:  1974-04       Impact factor: 4.219

9.  Intracellular binding and metabolism of imipramine and imipramine-N-oxide.

Authors:  M H Bickel; P L Gigon
Journal:  Chem Biol Interact       Date:  1971-08       Impact factor: 5.192

10.  AGRANULOCYTOSIS ASSOCIATED WITH IMIPRAMINE (TOFRANIL).

Authors:  S I HNATKO; J H STIRRAT; J VERCHOMIN; C G RAMSEY
Journal:  Can Med Assoc J       Date:  1965-01-02       Impact factor: 8.262

View more
  3 in total

1.  Effect of dithiocarb and dimethyl sulfoxide on irreversible binding of 14C-bromobenzene to rat liver microsomal protein.

Authors:  M Younes; C P Siegers; J G Filser
Journal:  Arch Toxicol       Date:  1979-09       Impact factor: 5.153

2.  The significance of covalent binding of catechols to proteins in vivo.

Authors:  H Remmer; M Scheulen; H Kappus; H M Bolt
Journal:  Arch Toxicol       Date:  1977-12-30       Impact factor: 5.153

3.  Brain concentrations of tricyclic antidepressants: single-dose kinetics and relationship to plasma concentrations in chronically dosed rats.

Authors:  R K Glotzbach; S H Preskorn
Journal:  Psychopharmacology (Berl)       Date:  1982       Impact factor: 4.530

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.